A dual-acting aldose reductase inhibitor impedes oxidative and carbonyl stress in tissues of fructose- and streptozotocin-induced rats: comparison with antioxidant stobadine
出版年份 2023 全文链接
标题
A dual-acting aldose reductase inhibitor impedes oxidative and carbonyl stress in tissues of fructose- and streptozotocin-induced rats: comparison with antioxidant stobadine
作者
关键词
-
出版物
DRUG AND CHEMICAL TOXICOLOGY
Volume -, Issue -, Pages 1-11
出版商
Informa UK Limited
发表日期
2023-10-05
DOI
10.1080/01480545.2023.2262164
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cemtirestat, an aldose reductase inhibitor and antioxidant compound, induces ocular defense against oxidative and inflammatory stress in rat models for glycotoxicity
- (2023) Tala Reihanifar et al. CELL BIOCHEMISTRY AND FUNCTION
- Caffeic acid regulates glucose homeostasis and inhibits purinergic and cholinergic activities while abating oxidative stress and dyslipidaemia in fructose-streptozotocin-induced diabetic rats
- (2022) Veronica F Salau et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Nature-Inspired O-Benzyl Oxime-Based Derivatives as New Dual-Acting Agents Targeting Aldose Reductase and Oxidative Stress
- (2022) Lidia Ciccone et al. Biomolecules
- Novel Hydroxychalcone-Based Dual Inhibitors of Aldose Reductase and α-Glucosidase as Potential Therapeutic Agents against Diabetes Mellitus and Its Complications
- (2022) Xiaonan Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Strategies in synthetic design and structure–activity relationship studies of novel heterocyclic scaffolds as aldose reductase‐2 inhibitors
- (2022) Shaikh Yahya et al. ARCHIV DER PHARMAZIE
- Novel topical esmolol hydrochloride improves wound healing in diabetes by inhibiting aldose reductase, generation of advanced glycation end products, and facilitating the migration of fibroblasts
- (2022) Sudhir A. Kulkarni et al. Frontiers in Endocrinology
- Protective Effects of Novel Substituted Triazinoindole Inhibitors of Aldose Reductase and Epalrestat in Neuron-like PC12 Cells and BV2 Rodent Microglial Cells Exposed to Toxic Models of Oxidative Stress: Comparison with the Pyridoindole Antioxidant Stobadine
- (2021) Zubeyir Elmazoglu et al. NEUROTOXICITY RESEARCH
- Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications
- (2021) Lucia Kovacikova et al. MOLECULES
- Aldose Reductase: a cause and a potential target for the treatment of diabetic complications
- (2021) Sapna Thakur et al. ARCHIVES OF PHARMACAL RESEARCH
- Lipid Peroxide-Derived Reactive Carbonyl Species as Mediators of Oxidative Stress and Signaling
- (2021) Md. Sanaullah Biswas et al. Frontiers in Plant Science
- Antioxidant Mechanisms in the Neuroprotective Action of Cemtirestat: Studies in Chemical Models, Liposomes and Rat Brain Cortical Slices
- (2020) Marta Soltesova Prnova et al. NEUROSCIENCE
- 3-Mercapto-5H-1,2,4-Triazino[5,6-b]Indole-5-Acetic Acid (Cemtirestat) Alleviates Symptoms of Peripheral Diabetic Neuropathy in Zucker Diabetic Fatty (ZDF) Rats: A Role of Aldose Reductase
- (2019) Marta Soltesova Prnova et al. NEUROCHEMICAL RESEARCH
- Dicarbonyls Generation, Toxicities, Detoxifications and Potential roles in Diabetes Complications
- (2019) Sultan Alouffi et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- High dietary n6/n3 ratio decreases eicosapentaenoic to arachidonic acid ratios and upregulates NFκB/p50 expression in short-term low-dose streptozotocin and high-fructose rat model of diabetes
- (2019) Kristina Starčević et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Dietary Fructose and the Metabolic Syndrome
- (2019) Taskinen et al. Nutrients
- Triglyceride-lowering effect of the aldose reductase inhibitor cemtirestat—another factor that may contribute to attenuation of symptoms of peripheral neuropathy in STZ-diabetic rats
- (2019) Marta Soltesova Prnova et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- The Antidiabetic Activity ofNigella sativaand Propolis on Streptozotocin-Induced Diabetes and Diabetic Nephropathy in Male Rats
- (2017) Haddad A. El Rabey et al. Evidence-based Complementary and Alternative Medicine
- Epalrestat Stimulated Oxidative Stress, Inflammation, and Fibrogenesis in Mouse Liver
- (2017) Yuan Le et al. TOXICOLOGICAL SCIENCES
- Dietary Sugars and Endogenous Formation of Advanced Glycation Endproducts: Emerging Mechanisms of Disease
- (2017) Manuela Aragno et al. Nutrients
- Epalrestat Upregulates Heme Oxygenase-1, Superoxide Dismutase, and Catalase in Cells of the Nervous System
- (2016) Kaori Yama et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Lutein attenuates oxidative stress markers and ameliorates glucose homeostasis through polyol pathway in heart and kidney of STZ-induced hyperglycemic rat model
- (2016) Gurunathan Sharavana et al. EUROPEAN JOURNAL OF NUTRITION
- Identification of Novel Aldose Reductase Inhibitors Based on Carboxymethylated Mercaptotriazinoindole Scaffold
- (2015) Milan Stefek et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes
- (2014) Rachel D. Wilson et al. Pharmacological Reports
- Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products
- (2013) Giancarlo Aldini et al. FREE RADICAL RESEARCH
- Epalrestat increases intracellular glutathione levels in Schwann cells through transcription regulation
- (2013) Keisuke Sato et al. Redox Biology
- Novel Hexahydropyridoindole Derivative as Prospective Agent Against Oxidative Damage in Pancreatic βCells
- (2012) Lucia Rackova et al. Medicinal Chemistry
- Effect of long term, non cholesterol lowering dose of fluvastatin treatment on oxidative stress in brain and peripheral tissues of streptozotocin-diabetic rats
- (2010) Ahmet Cumaoğlu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Epalrestat: An Aldose Reductase Inhibitor for the Treatment of Diabetic Neuropathy
- (2008) Mary Ann Ramirez et al. PHARMACOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started